Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2018-07-17 Legal Proceedings Report
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
Legal Proceedings Report Classification · 1% confidence The document begins with an 'RNS Number' and is dated July 17, 2018. It announces a specific corporate event: the granting of a US Patent for a therapeutic compound (VAL301) and discusses the market opportunity. The text concludes with a standard disclaimer stating, 'This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014,' and ends with the RNS service footer. This structure is characteristic of a general regulatory news service announcement, which fits the Regulatory Filings (RNS) category, as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a dividend notice (DIV).
2018-07-17 English
Notice of GM
Regulatory Filings Classification · 1% confidence The document is an official announcement filed via RNS (RNS Number : 9238T) dated July 6, 2018. The title explicitly states it is a 'SHAREHOLDER CIRCULAR AND NOTICE OF GENERAL MEETING'. This document announces the publication and posting of materials for an upcoming General Meeting where shareholder resolutions (allotment of shares, disapplication of pre-emptive rights) will be proposed. Since the document is short and its primary function is to announce the availability of the Circular and the details of the General Meeting, it relates closely to shareholder voting and meeting information. While it announces a circular, the core subject matter is the meeting itself and the proposals therein. The closest fit among the specific codes is 'AGM-R' (AGM Information/Materials), as a General Meeting is functionally similar to an AGM in terms of shareholder interaction, or potentially 'PSI' (Proxy Solicitation & Information Statement) as it is a circular sent to shareholders regarding a meeting. However, the document explicitly mentions a 'Notice of General Meeting' and the content relates to shareholder resolutions, making it highly relevant to meeting materials. Given the options, 'AGM-R' is the best fit for materials related to a General Meeting, although 'PSI' is also plausible. Since it is a formal notice and circular for a meeting, I will classify it as AGM-R, representing general meeting materials.
2018-07-06 English
VAL401 Update
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 3219R' and is dated June 14, 2018. It provides an update on a clinical trial (VAL401) focusing on commercial development, advisory board findings, convention attendance (BIO International Convention), and patent notification. The closing section explicitly states: 'This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014' and ends with a footer referencing 'RNS, the news service of the London Stock Exchange' and 'Primary Information Provider in the United Kingdom'. This structure and explicit reference strongly indicate a general regulatory news service announcement, which maps directly to the 'Regulatory Filings' category (RNS), as it is not a specific financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or DIRS).
2018-06-14 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1473 characters) and contains the header 'RNS Number : 1652P'. The content describes a 'Price Monitoring Extension' related to trading on the London Stock Exchange and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general Regulatory Filings category.
2018-05-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 8629N' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in major shareholdings, which directly corresponds to the definition of 'Major Shareholding Notification'. The filing date is May 11, 2018, and it details the resulting share position (4.54%) after an acquisition/disposal of voting rights. This fits the criteria for Major Shareholding Notification (MRQ) better than the general Regulatory Filings (RNS) category, although it is distributed via RNS.
2018-05-11 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1174 characters) and contains the header 'RNS Number : 2351N' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement. Since it is a brief regulatory notification provided via the RNS service and does not contain detailed financial statements, management discussion, or proxy materials, it fits best into the general regulatory announcement category, RNS, as it is a miscellaneous regulatory filing that doesn't fit the other specific codes.
2018-05-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.